TelyRx Holdings Inc.
TELY.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -4.68M | -3.10M | -- | -38.00K | |
| Total Depreciation and Amortization | 97.00K | 133.00K | -- | 136.00K | |
| Total Amortization of Deferred Charges | 155.00K | 138.00K | -- | -- | |
| Total Other Non-Cash Items | 1.55M | 224.00K | -- | 143.00K | |
| Change in Net Operating Assets | 1.56M | 2.18M | -- | -108.00K | |
| Cash from Operations | -1.32M | -427.00K | -- | 133.00K | |
| Capital Expenditure | -38.00K | -122.00K | -- | -162.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 640.00K | -142.00K | -- | -239.00K | |
| Cash from Investing | 602.00K | -264.00K | -- | -401.00K | |
| Total Debt Issued | 10.15M | 2.00M | -- | -- | |
| Total Debt Repaid | -9.25M | -111.00K | -- | -16.00K | |
| Issuance of Common Stock | 23.83M | -- | -- | -- | |
| Repurchase of Common Stock | -- | 0.00 | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 24.72M | 1.89M | -- | -16.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 24.01M | 1.20M | -- | -284.00K | |